- Report
- May 2024
- 135 Pages
Global
From €6214EUR$6,499USD£5,201GBP
- Report
- June 2024
- 200 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- July 2022
- 100 Pages
Global
From €2629EUR$2,750USD£2,201GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,161GBP
The Inguinal Hernia Drug market is a subset of the Gastrointestinal Drugs market. It is composed of drugs used to treat inguinal hernias, which are protrusions of abdominal tissue through a weak spot in the abdominal wall. These drugs are typically used to reduce pain and discomfort associated with the hernia, as well as to prevent further complications. Common drugs used to treat inguinal hernias include analgesics, antibiotics, and anti-inflammatory medications. Surgery is also an option for treating inguinal hernias, but is usually reserved for more severe cases.
Some companies in the Inguinal Hernia Drug market include Pfizer, Merck, Novartis, and Johnson & Johnson. These companies produce a variety of drugs used to treat inguinal hernias, including analgesics, antibiotics, and anti-inflammatory medications. Show Less Read more